Eutilex Competitors and Similar CompaniesClear all

Eutilex's competitors and similar companies include Zymeworks, Coherus BioSciences and Neovii.
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Coherus BioSciences
Coherus BioSciences
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Founding Date
Founding Date
2015
Founding Date
2003
Founding Date
2010
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
KR HQ
Locations
Vancouver, CA HQ
Seattle, US
Locations
Redwood City, US HQ
Camarillo, US
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Employees
Employees
90
Employees
45519% increase
Employees
30615% decrease
Employees
1031% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
735.3 m
Valuation ($)
173.2 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
3.7 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.9
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
81.25%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
₩131.7m (FY, 2023)
Revenue (est.)
$76m (FY, 2023)
Revenue (est.)
$257.2m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$159m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
₩217.5m (FY, 2023)
Gross profit
N/A
Gross profit
$98.3m (FY, 2023)
Gross profit
N/A
Net income
Net income
(₩28.3b) (FY, 2023)
Net income
($118.7m) (FY, 2023)
Net income
($237.9m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 18.9m
Total funding raised
$ 125.9m
Total funding raised
$ 174.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company
Coherus BioSciences
HQ
Redwood City, US
Employees
306↓ 15% decrease

Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.

View company
Neovii
HQ
Rapperswil-Jona, CH
Employees
103↓ 1% decrease

Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.

View company